when does the patent for semaglutide expire Off-patent in 2026: next revolution in anti-obesity medications Semaglutide Patent Expiry: ?50,000 Cr

Certain individuals in Utah should refrain from semaglutide if they have a personal or familial history of medullary thyroid cancer or specific genetic syndromes

The semaglutide Summary of Product Characteristics (SmPC) notes the diabetic retinopathy findings from SUSTAIN-6 and recommends appropriate monitoring for patients with diabetic retinopathy

The TGA said it first identified the potential association between GLP-1 drugs and NAION in 2024 when a study was published in the Journal of the American Medical Association (JAMA) Ophthalmology

If you remember within 4 days of your scheduled injection, take the dose as soon as possible and resume your regular weekly schedule

Our vitamin B12 IV therapy guide covers dosing